Sale of 5 shares at $13.716 per share.
Reporting Person Dolan Oliver · Officer Title Senior Vice President, Finance · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001193125-26-390556 · filed 2026-09-14 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Korro Bio, Inc. (KRRO)." Disclosed 2026-09-14. https://desqlong.com/cards/0001193125-26-390556-1 (retrieved 2026-09-26).